ARTICLE | Company News
Commonwealth Laboratories sales and marketing update
July 13, 2015 7:00 AM UTC
Commonwealth launched its IBSchek ELISA-based blood test to diagnose irritable bowel syndrome (IBS). The laboratory-developed test (LDT) detects antibodies against cytolethal distending toxin B (CdtB...